Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient

Bone Marrow Transplantation

Volumn 45, Issue 6, 2010, Pages 1115-1116

  Oosterhof, L ^a   Christensen, C B ^b   Sengelov H ^a  

^a Department of Hematology   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CASPOFUNGIN; CYCLOSPORIN A; FLUCONAZOLE; IMMUNOGLOBULIN; METHOTREXATE; STEROID; TRIMETHOPRIM; VALACICLOVIR;

ABNORMAL LABORATORY RESULT; ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOPSY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS INFECTION; COUGHING; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; FLU LIKE SYNDROME; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LOWER RESPIRATORY TRACT INFECTION; LUNG BIOPSY; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MACULOPAPULAR RASH; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY FAILURE; THORAX RADIOGRAPHY; VIRUS DETECTION; CORONAVIRUS; DISEASE TRANSMISSION; FATALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; RESPIRATORY TRACT DISEASES; VIROLOGY;

ADULT; CORONAVIRUS; DISEASE TRANSMISSION, INFECTIOUS; FATAL OUTCOME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; RESPIRATORY TRACT DISEASES;

EID: 77954862287     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.292     Document Type: Letter

References (8)

1. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RT, Wolthers KC et al. Identification of a new human coronavirus. Nat Med 2004; 10: 368-373.
2. van der Hoek L. Human coronaviruses: what do they cause? Antivir Ther 2007; 12: 651-658.
3. Fischer SA. Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV. Transplantation 2008; 86: 1327-1339.
4. Maury S, Mary JY, Rabian C, Swarzinger M, Toubert A, Scieux C et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001; 115: 630-641.
5. Bjorklund A, Aschan J, Labopin M, Remberger M, Ringden O, Winiarski J et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 40: 1055-1062. (Pubitemid 350142559)
6. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995; 86: 3979-3986.
7. Chakrabarti S, Collingham KE, Marshall T, Holder K, Gentle T, Hale G et al. Respiratory virus infections in adult T celldepleted transplant recipients: the role of cellular immunity. Transplantation 2001; 72: 1460-1463.
8. Kantrow SP, Hackman RC, Boeckh M, Myerson D, Crawford SW. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079-1086.